How Inhibikase Therapeutics, Inc. stacks up

IKT · against 241 other Healthcare companies of similar size

Overall

41/ 100

Below the middle of the pack.

Ranked #134 of 242 · scores higher than 42% of peers

Bars: peers in each 10-point band of the overall score

55 peers with an overall score of 40–49, including IKT · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#156 of 244Score 8 / 100 · beats 11%

Growth—Not enough reported data

Profitability#174 of 246Score 17 / 100 · beats 27%Risk#12 of 260Lower relative risk · safety 97 · beats 96%

Ranking by overall score

Top 5 and the companies ranked around IKT

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Q32 Bio Inc.QTTB · US-listed	261M USD	97	93	—	98	0 / 2
2	Beijing Chunlizhengda Medical Instruments Co., Ltd.1858.HK · Hong Kong	2.9B HKD (≈$365M)	84	99	63	86	0 / 2
2	Compugen Ltd.CGEN.TA · Middle East	592M ILS (≈$160M)	84	99	99	96	1 / 2
4	Clinuvel Pharmaceuticals LimitedCUV.AX · Australia & NZ	356M AUD (≈$235M)	81	98	35	97	0 / 2
5	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	80	98	35	92	0 / 2
⋯
130	Stratec SESBS.DE · Europe	304M EUR (≈$334M)	42	50	21	49	1 / 2
134	Yungjin Pharm. Co., Ltd.003520.KS · South Korea	171.0B KRW (≈$123M)	41	32	39	37	1 / 2
134	Tanvex BioPharma, Inc.6541.TW · Taiwan	7.2B TWD (≈$224M)	41	8	99	10	1 / 2
134	Contineum Therapeutics, Inc.CTNM · US-listed	365M USD	41	8	—	21	0 / 2
134	Inhibikase Therapeutics, Inc.IKT · US-listed	207M USD	41	8	—	17	0 / 2
134	Immuneering CorporationIMRX · US-listed	238M USD	41	8	—	20	0 / 2
134	Invivyd, Inc.IVVD · US-listed	172M USD	41	8	74	8	0 / 2
134	Orthofix Medical Inc.OFIX · US-listed	354M USD	41	39	52	30	1 / 2
141	Ildong Pharmaceutical Co., Ltd.249420.KS · South Korea	384.1B KRW (≈$277M)	40	72	16	47	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…